Bykerk, V. P., Blauvelt, A., Curtis, J. R., Gaujoux‐Viala, C., Kvien, T. K., Winthrop, K., . . . Haraoui, B. (2021). Associations Between Safety of Certolizumab Pegol, Disease Activity, and Patient Characteristics, Including Corticosteroid Use and Body Mass Index. Wiley.
Chicago Style (17th ed.) CitationBykerk, Vivian P., et al. Associations Between Safety of Certolizumab Pegol, Disease Activity, and Patient Characteristics, Including Corticosteroid Use and Body Mass Index. Wiley, 2021.
MLA (8th ed.) CitationBykerk, Vivian P., et al. Associations Between Safety of Certolizumab Pegol, Disease Activity, and Patient Characteristics, Including Corticosteroid Use and Body Mass Index. Wiley, 2021.
Warning: These citations may not always be 100% accurate.